Category - Developments

Developments

Braeburn Pharma commends HHS plan on opioid addition

Closely-held Braeburn Pharmaceuticals has commended U.S. Department of Health and Human Services (HHS) Secretary Sylvia Burwell on her announcement that HHS will expand access to medication-assisted treatment as part of...

September 18, 2015

Developments

Can-Fite gets FDA fast track for liver cancer drug

The FDA has granted Can-Fite BioPharma’s (NYSE MKT:CANF; TASE:CFBI) drug candidate, CF102, fast track designation asv a second line treatment for hepatocellular carcinoma (HCC), the most common form of liver cancer...

September 17, 2015

Category - Developments

Braeburn Pharma commends HHS plan on opioid addition

Can-Fite gets FDA fast track for liver cancer drug

General

More